Interventional Pulmonology Market By Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems), By Indication (Asthma, COPD, Lung Cancer, Tracheal and Bronchial Stenosis, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Interventional Pulmonology Market

Interventional pulmonology is a subspecialty of pulmonary medicine concerned with the diagnosis and treatment of neoplastic and non-neoplastic diseases of the airways, lungs, and pleura using minimally invasive endoscopic and percutaneous procedures. Endoscopy and other tools are used in interventional pulmonology to diagnose and treat lung and chest conditions such as COPD (Emphysema), asthma, lung cancer, and tuberculosis. Interventional pulmonology procedures use image-guided techniques such as computed tomography, fluoroscopy, and ultrasound to diagnose and treat the specific site affected by pain or cancer. Interventional pulmonology is most commonly used in conjunction with other cancer treatments like surgery, chemotherapy, and radiation therapy.

The increase in healthcare expenditure is driving the growth of the interventional pulmonology market as more people can afford better medical services. With higher disposable income, individuals are willing to spend more on their health and well-being, leading to an increase in demand for pulmonology services. The growing focus on preventative care and early diagnosis of respiratory diseases is also contributing to the growth of the market. In addition, an increase in the prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer is driving the demand for pulmonology services, especially in developed countries. The increasing healthcare expenditure, growing focus on preventative care, increasing prevalence of respiratory diseases, and advancements in medical technology are the key drivers of the interventional pulmonology market. All these factors are expected to boost the growth of the market during the forecast period.

Minimally invasive procedures are in high demand because they are associated with fewer complications and shorter recovery times. Interventional pulmonology procedures are minimally invasive and can be performed under local anesthesia. Furthermore, technological advancements have resulted in the development of new interventional pulmonology devices and procedures. These procedures are less invasive and have shorter recovery times. Favorable reimbursement policies are another driver of market expansion. For instance, in the U.S., Medicare covers interventional pulmonology procedures. This is expected to fuel the country's market growth.

The increasing prevalence of chronic respiratory diseases, advancements in technology and treatments, and growing demand for specialized care are driving the growth of the pulmonology market. The global pulmonology market is also benefiting from the increasing number of medical tourism destinations that are attracting patients from around the world for advanced pulmonology treatments. This has led to a growing demand for pulmonologists and specialized respiratory clinics that offer cutting-edge treatments and services. With these trends expected to continue in the future, it is a lucrative market opportunity for healthcare providers and investors. All these advancements in the interventional pulmonology sector are projected to provide growth opportunities for the key players operating in the market in the upcoming years. 

The interventional pulmonology market is segmented into product, indication, end user, and region. On the basis of product, the market is classified into bronchoscopes, electromagnetic navigation bronchoscopy system, pleuroscopes, respiratory endotherapy devices, airway stents, pleural catheters, endobronchial valves, and bronchial thermoplasty systems. On the basis of indication, it is divided into asthma, COPD, lung cancer, tracheal and bronchial stenosis, and others. On the basis of end user, it is classified into hospitals, ambulatory surgical centers, diagnostic centers, specialty clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, Italy, France, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA).

The key players profiled in the study include Huger Medical Instrument Co. Ltd, Medtronic Plc, Boston Scientific Corporation, Olympus Corporation, FUJIFILM Corporation, Becton, Smith’s Group Plc, Cook Medical, Vygon, and Clarus Medical LLC. The major players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch, and expansion to remain competitive and gain an advantage over the competitors in the market. For instance, in August 2020, The Olympus Corporation BF-Q180 bronchoscope was recalled after failing a 510(k) clearance and being connected to a higher risk of patient infections than other Olympus Medical Systems Corporation bronchoscopes.

Key Market Insights

By product, the bronchoscopes segment was the highest revenue contributor to the market in 2021. However, the endobronchial valves segment is estimated to be the fastest growing during the forecast period.

By indication, the asthma segment dominated the market share in 2021. However, the lung cancer segment is expected to be the fastest growing during the forecast years.

Based on end user, the hospitals segment was the highest revenue contributor to the market in 2021 and is projected to be the fastest growing during the forecast time

Based on region, North America was the highest revenue contributor to the market in 2021 and Asia-Pacific is anticipated to show the fastest growth by 2031

 

 

 

Overview

The global interventional pulmonology market is anticipated to reach $ 6.9 billion by 2031, growing from $3.7 billion in 2021 at a CAGR of 5.0% from 2022 to 2031.

Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions related to the lungs and chest. These procedures may be offered by pulmonologists (lung specialists) who have undergone extra training. Interventional pulmonologists offer diagnostic and treatment services for major lung problems including compressed airways, tumors, cancer, tuberculosis, and other airway stricture causes. The increase in healthcare expenditure globally is driving the growth of the pulmonology market. Governments of various countries are investing in healthcare infrastructure and services, and individuals are becoming more aware of the importance of preventive healthcare. This has led to an increase in the demand for pulmonology services, which is driving the growth of the interventional pulmonology market.

The need for affordable and accessible respiratory care is crucial, and healthcare providers need to work towards reducing the cost of pulmonology treatments to ensure better health outcomes for patients globally. The cost of purchasing specialized medical equipment used in pulmonology is also high, which can be a challenge for small-scale clinics and hospitals, especially in low-income countries. This can further reduce the reach of advanced pulmonology treatments and increase the gap in the quality of healthcare between developed and developing countries, which is anticipated to hamper the interventional pulmonology market growth.

The increase in emphasis on developing innovative pulmonology products, as well as the rise of telemedicine services, are expected to create new market opportunities. Telemedicine services are helping pulmonologists to diagnose patients remotely and provide treatments that may not be available in the patient's location. Pulmonology technology advancements, such as minimally invasive surgical procedures, respiratory support devices, and imaging techniques, are driving the market expansion. This is expected to create new business opportunities for pulmonology market players and is likely to drive the market expansion in the future.

The COVID-19 pandemic has had a significant impact on the interventional pulmonology market. With the outbreak of the pandemic, there has been an increase in the demand for respiratory devices and equipment like ventilators, oxygen concentrators, and face masks. However, the pandemic has disrupted the supply chains of several pulmonology-related items, resulting in shortages and price increases. Furthermore, many hospitals and healthcare institutions delayed or canceled non-emergency treatments such as pulmonary function testing and sleep studies, resulting in lower income for pulmonologists and related businesses.

The key players profiled in this report include Huger Medical Instrument Co. Ltd, Medtronic Plc, Boston Scientific Corporation, Olympus Corporation, FUJIFILM Corporation, Becton, Smith’s Group Plc, Cook Medical, Vygon, and Clarus Medical LLC.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the interventional pulmonology market analysis from 2021 to 2031 to identify the prevailing interventional pulmonology market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the interventional pulmonology market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global interventional pulmonology market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ clarus medical ll

Scope of Interventional Pulmonology Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.4. Market dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.5. COVID-19 Impact Analysis on the market

3.6. Average Selling Price

3.7. Brand Share Analysis

3.8. Key Regulation Analysis

3.9. Market Share Analysis

3.10. Patent Landscape

3.11. Regulatory Guidelines

3.12. Value Chain Analysis

4.1. Overview

4.1.1. Market size and forecast

4.2. Bronchoscopes

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Electromagnetic Navigation Bronchoscopy System

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Pleuroscopes

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Respiratory Endotherapy Devices

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

4.6. Airway Stents

4.6.1. Key market trends, growth factors and opportunities

4.6.2. Market size and forecast, by region

4.6.3. Market share analysis by country

4.7. Pleural Catheters

4.7.1. Key market trends, growth factors and opportunities

4.7.2. Market size and forecast, by region

4.7.3. Market share analysis by country

4.8. Endobronchial Valves

4.8.1. Key market trends, growth factors and opportunities

4.8.2. Market size and forecast, by region

4.8.3. Market share analysis by country

4.9. Bronchial Thermoplasty Systems

4.9.1. Key market trends, growth factors and opportunities

4.9.2. Market size and forecast, by region

4.9.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Asthma

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. COPD

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Lung Cancer

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Tracheal and Bronchial Stenosis

5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

5.6. Others

5.6.1. Key market trends, growth factors and opportunities

5.6.2. Market size and forecast, by region

5.6.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Ambulatory Surgical Centers

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Diagnostic Centers

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

6.5. Specialty Clinics

6.5.1. Key market trends, growth factors and opportunities

6.5.2. Market size and forecast, by region

6.5.3. Market share analysis by country

6.6. Others

6.6.1. Key market trends, growth factors and opportunities

6.6.2. Market size and forecast, by region

6.6.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Product

7.2.3. Market size and forecast, by Indication

7.2.4. Market size and forecast, by End-user

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Product

7.2.5.1.3. Market size and forecast, by Indication

7.2.5.1.4. Market size and forecast, by End-user

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Product

7.2.5.2.3. Market size and forecast, by Indication

7.2.5.2.4. Market size and forecast, by End-user

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Product

7.2.5.3.3. Market size and forecast, by Indication

7.2.5.3.4. Market size and forecast, by End-user

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Product

7.3.3. Market size and forecast, by Indication

7.3.4. Market size and forecast, by End-user

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Product

7.3.5.1.3. Market size and forecast, by Indication

7.3.5.1.4. Market size and forecast, by End-user

7.3.5.2. UK

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Product

7.3.5.2.3. Market size and forecast, by Indication

7.3.5.2.4. Market size and forecast, by End-user

7.3.5.3. France

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Product

7.3.5.3.3. Market size and forecast, by Indication

7.3.5.3.4. Market size and forecast, by End-user

7.3.5.4. Spain

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Product

7.3.5.4.3. Market size and forecast, by Indication

7.3.5.4.4. Market size and forecast, by End-user

7.3.5.5. Italy

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Product

7.3.5.5.3. Market size and forecast, by Indication

7.3.5.5.4. Market size and forecast, by End-user

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Product

7.3.5.6.3. Market size and forecast, by Indication

7.3.5.6.4. Market size and forecast, by End-user

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Product

7.4.3. Market size and forecast, by Indication

7.4.4. Market size and forecast, by End-user

7.4.5. Market size and forecast, by country

7.4.5.1. China

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Product

7.4.5.1.3. Market size and forecast, by Indication

7.4.5.1.4. Market size and forecast, by End-user

7.4.5.2. Japan

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Product

7.4.5.2.3. Market size and forecast, by Indication

7.4.5.2.4. Market size and forecast, by End-user

7.4.5.3. India

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Product

7.4.5.3.3. Market size and forecast, by Indication

7.4.5.3.4. Market size and forecast, by End-user

7.4.5.4. South Korea

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Product

7.4.5.4.3. Market size and forecast, by Indication

7.4.5.4.4. Market size and forecast, by End-user

7.4.5.5. Australia

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Product

7.4.5.5.3. Market size and forecast, by Indication

7.4.5.5.4. Market size and forecast, by End-user

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Product

7.4.5.6.3. Market size and forecast, by Indication

7.4.5.6.4. Market size and forecast, by End-user

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Product

7.5.3. Market size and forecast, by Indication

7.5.4. Market size and forecast, by End-user

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Product

7.5.5.1.3. Market size and forecast, by Indication

7.5.5.1.4. Market size and forecast, by End-user

7.5.5.2. United Arab Emirates

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Product

7.5.5.2.3. Market size and forecast, by Indication

7.5.5.2.4. Market size and forecast, by End-user

7.5.5.3. Saudi Arabia

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Product

7.5.5.3.3. Market size and forecast, by Indication

7.5.5.3.4. Market size and forecast, by End-user

7.5.5.4. South Africa

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Product

7.5.5.4.3. Market size and forecast, by Indication

7.5.5.4.4. Market size and forecast, by End-user

7.5.5.5. Rest of LAMEA

7.5.5.5.1. Key market trends, growth factors and opportunities

7.5.5.5.2. Market size and forecast, by Product

7.5.5.5.3. Market size and forecast, by Indication

7.5.5.5.4. Market size and forecast, by End-user

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2021

9.1. Medtronic Plc

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.2. Boston Scientific Corporation

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.3. Olympus Corporation

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.4. fujifilm corporation

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.5. Becton

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.6. Smith’s Group Plc

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.7. cook medical

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.8. Vygon

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.9. clarus medical llc

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.10. Huger Medical Instrument Co. Ltd

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapsho

LIST OF TABLES

TABLE 01. GLOBAL INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 02. INTERVENTIONAL PULMONOLOGY MARKET FOR BRONCHOSCOPES, BY REGION, 2021-2031 ($MILLION)

TABLE 03. INTERVENTIONAL PULMONOLOGY MARKET FOR ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY SYSTEM, BY REGION, 2021-2031 ($MILLION)

TABLE 04. INTERVENTIONAL PULMONOLOGY MARKET FOR PLEUROSCOPES, BY REGION, 2021-2031 ($MILLION)

TABLE 05. INTERVENTIONAL PULMONOLOGY MARKET FOR RESPIRATORY ENDOTHERAPY DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 06. INTERVENTIONAL PULMONOLOGY MARKET FOR AIRWAY STENTS, BY REGION, 2021-2031 ($MILLION)

TABLE 07. INTERVENTIONAL PULMONOLOGY MARKET FOR PLEURAL CATHETERS, BY REGION, 2021-2031 ($MILLION)

TABLE 08. INTERVENTIONAL PULMONOLOGY MARKET FOR ENDOBRONCHIAL VALVES, BY REGION, 2021-2031 ($MILLION)

TABLE 09. INTERVENTIONAL PULMONOLOGY MARKET FOR BRONCHIAL THERMOPLASTY SYSTEMS, BY REGION, 2021-2031 ($MILLION)

TABLE 10. GLOBAL INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 11. INTERVENTIONAL PULMONOLOGY MARKET FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)

TABLE 12. INTERVENTIONAL PULMONOLOGY MARKET FOR COPD, BY REGION, 2021-2031 ($MILLION)

TABLE 13. INTERVENTIONAL PULMONOLOGY MARKET FOR LUNG CANCER, BY REGION, 2021-2031 ($MILLION)

TABLE 14. INTERVENTIONAL PULMONOLOGY MARKET FOR TRACHEAL AND BRONCHIAL STENOSIS, BY REGION, 2021-2031 ($MILLION)

TABLE 15. INTERVENTIONAL PULMONOLOGY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 16. GLOBAL INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 17. INTERVENTIONAL PULMONOLOGY MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 18. INTERVENTIONAL PULMONOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 19. INTERVENTIONAL PULMONOLOGY MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 20. INTERVENTIONAL PULMONOLOGY MARKET FOR SPECIALTY CLINICS, BY REGION, 2021-2031 ($MILLION)

TABLE 21. INTERVENTIONAL PULMONOLOGY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 22. INTERVENTIONAL PULMONOLOGY MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 23. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 24. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 25. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 26. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 27. U.S. INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 28. U.S. INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 29. U.S. INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 30. CANADA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 31. CANADA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 32. CANADA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 33. MEXICO INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 34. MEXICO INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 35. MEXICO INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 36. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 37. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 38. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 39. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 40. GERMANY INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 41. GERMANY INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 42. GERMANY INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 43. UK INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 44. UK INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 45. UK INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 46. FRANCE INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 47. FRANCE INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 48. FRANCE INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 49. SPAIN INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 50. SPAIN INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 51. SPAIN INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 52. ITALY INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 53. ITALY INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 54. ITALY INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 55. REST OF EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 56. REST OF EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 57. REST OF EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 58. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 59. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 60. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 61. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 62. CHINA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 63. CHINA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 64. CHINA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 65. JAPAN INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 66. JAPAN INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 67. JAPAN INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 68. INDIA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 69. INDIA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 70. INDIA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 71. SOUTH KOREA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 72. SOUTH KOREA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 73. SOUTH KOREA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 74. AUSTRALIA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 75. AUSTRALIA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 76. AUSTRALIA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 77. REST OF ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 78. REST OF ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 79. REST OF ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 80. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 81. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 82. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 83. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 84. BRAZIL INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 85. BRAZIL INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 86. BRAZIL INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 87. UNITED ARAB EMIRATES INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 88. UNITED ARAB EMIRATES INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 89. UNITED ARAB EMIRATES INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 90. SAUDI ARABIA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 91. SAUDI ARABIA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 92. SAUDI ARABIA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 93. SOUTH AFRICA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 94. SOUTH AFRICA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 95. SOUTH AFRICA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 96. REST OF LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 97. REST OF LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)

TABLE 98. REST OF LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)

TABLE 99. MEDTRONIC PLC: KEY EXECUTIVES

TABLE 100. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 101. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES

TABLE 102. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 103. OLYMPUS CORPORATION: KEY EXECUTIVES

TABLE 104. OLYMPUS CORPORATION: COMPANY SNAPSHOT

TABLE 105. FUJIFILM CORPORATION: KEY EXECUTIVES

TABLE 106. FUJIFILM CORPORATION: COMPANY SNAPSHOT

TABLE 107. BECTON: KEY EXECUTIVES

TABLE 108. BECTON: COMPANY SNAPSHOT

TABLE 109. SMITH’S GROUP PLC: KEY EXECUTIVES

TABLE 110. SMITH’S GROUP PLC: COMPANY SNAPSHOT

TABLE 111. COOK MEDICAL: KEY EXECUTIVES

TABLE 112. COOK MEDICAL: COMPANY SNAPSHOT

TABLE 113. VYGON: KEY EXECUTIVES

TABLE 114. VYGON: COMPANY SNAPSHOT

TABLE 115. CLARUS MEDICAL LLC: KEY EXECUTIVES

TABLE 116. CLARUS MEDICAL LLC: COMPANY SNAPSHOT

TABLE 117. HUGER MEDICAL INSTRUMENT CO. LTD: KEY EXECUTIVES

TABLE 118. HUGER MEDICAL INSTRUMENT CO. LTD: COMPANY SNAPSHOT LIST OF FIGURES

FIGURE 01. INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN INTERVENTIONAL PULMONOLOGY MARKET (2022-2031)

FIGURE 04. PORTER FIVE-1

FIGURE 05. PORTER FIVE-2

FIGURE 06. PORTER FIVE-3

FIGURE 07. PORTER FIVE-4

FIGURE 08. PORTER FIVE-5

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALINTERVENTIONAL PULMONOLOGY MARKET

FIGURE 10. IMPACT OF KEY REGULATION: INTERVENTIONAL PULMONOLOGY MARKET

FIGURE 11. MARKET SHARE ANALYSIS: INTERVENTIONAL PULMONOLOGY MARKET

FIGURE 12. PATENT ANALYSIS BY COMPANY

FIGURE 13. PATENT ANALYSIS BY COUNTRY

FIGURE 14. REGULATORY GUIDELINES: INTERVENTIONAL PULMONOLOGY MARKET

FIGURE 15. VALUE CHAIN ANALYSIS: INTERVENTIONAL PULMONOLOGY MARKET

FIGURE 16. INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR BRONCHOSCOPES, BY COUNTRY 2021 AND 2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY SYSTEM, BY COUNTRY 2021 AND 2031(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR PLEUROSCOPES, BY COUNTRY 2021 AND 2031(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR RESPIRATORY ENDOTHERAPY DEVICES, BY COUNTRY 2021 AND 2031(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR AIRWAY STENTS, BY COUNTRY 2021 AND 2031(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR PLEURAL CATHETERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR ENDOBRONCHIAL VALVES, BY COUNTRY 2021 AND 2031(%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR BRONCHIAL THERMOPLASTY SYSTEMS, BY COUNTRY 2021 AND 2031(%)

FIGURE 25. INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021(%)

FIGURE 26. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR ASTHMA, BY COUNTRY 2021 AND 2031(%)

FIGURE 27. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR COPD, BY COUNTRY 2021 AND 2031(%)

FIGURE 28. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR LUNG CANCER, BY COUNTRY 2021 AND 2031(%)

FIGURE 29. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR TRACHEAL AND BRONCHIAL STENOSIS, BY COUNTRY 2021 AND 2031(%)

FIGURE 30. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 31. INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021(%)

FIGURE 32. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)

FIGURE 33. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 34. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 35. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR SPECIALTY CLINICS, BY COUNTRY 2021 AND 2031(%)

FIGURE 36. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL PULMONOLOGY MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 37. INTERVENTIONAL PULMONOLOGY MARKET BY REGION, 2021

FIGURE 38. U.S. INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 39. CANADA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 40. MEXICO INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 41. GERMANY INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 42. UK INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 43. FRANCE INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 44. SPAIN INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 45. ITALY INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 46. REST OF EUROPE INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 47. CHINA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 48. JAPAN INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 49. INDIA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 50. SOUTH KOREA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 51. AUSTRALIA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 52. REST OF ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 53. BRAZIL INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 54. UNITED ARAB EMIRATES INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 55. SAUDI ARABIA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 56. SOUTH AFRICA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 57. REST OF LAMEA INTERVENTIONAL PULMONOLOGY MARKET, 2021-2031 ($MILLION)

FIGURE 58. TOP WINNING STRATEGIES, BY YEAR

FIGURE 59. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 60. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 61. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 62. COMPETITIVE DASHBOARD

FIGURE 63. COMPETITIVE HEATMAP: INTERVENTIONAL PULMONOLOGY MARKET

FIGURE 64. TOP PLAYER POSITIONING, 202